Pharma channel feed – Endpoints News

Pharma channel feed

Small biotech joins list of health companies taking a trip to Trump's Mar-a-Lago

3 months ago

J&J touts new survival data pitting lung cancer combo against AstraZeneca's rival

3 months ago

Trump tariffs would increase costs for almost every biopharma company, survey claims

3 months ago

Senate confirms Makary as FDA chief with agency cuts, return-to-office in force

3 months ago

Eisai cuts Leqembi 2027 sales forecast by half but expects 'continued growth'

3 months ago

Senate committee backs Dr. Oz's nomination to lead CMS

3 months ago

Axsome reports Phase 3 win for Sunosi in adults with ADHD, with a high-dose caveat

3 months ago

GSK scores FDA approval for antibiotic to treat uncomplicated UTIs

3 months ago

Merck strikes deal for heart drug, worth up to $2B, with China’s Hengrui

3 months ago

Three major questions on pharma tariffs Trump claims are on the way

3 months ago

AbbVie files trade secrets suit against ADC competitor

3 months ago

Liver cancer drug combo gets second FDA rejection over manufacturing issues

3 months ago

Trump think tank resurrects international drug pricing model to go after 'global freeloading'

3 months ago

Alnylam hopes its broad ATTR-CM label can give Amvuttra an edge in heart disease

3 months ago

BARDA cancels annual biomedical event for industry, government reps

3 months ago

The buildup to Chimerix's $935M exit to Jazz, with more than half a dozen parties intrigued

3 months ago

FDA approves Novartis’ Fabhalta in another rare kidney disease

3 months ago

AstraZeneca broadens presence in China, promising $8B+ to Harbour and Syneron

3 months ago

Johnson & Johnson earmarks $55B to boost US capacity

3 months ago

Updated: FDA approves Alnylam’s Amvuttra in ATTR-CM, kicking off competition with Pfizer, BridgeBio

3 months ago

CDC vaccine meeting, delayed earlier this year, is rescheduled

3 months ago

Akero exec calls FDA's accelerated approval guidance for MASH drugs 'bizarre'

3 months ago

Novo Nordisk says new early R&D structure will ‘future-proof’ its business

3 months ago

Paratek boosts commercial portfolio in move to buy Optinose and its nasal spray

3 months ago

First page Previous page 13 14 151617 18 19 Next page Last page